Otherwise, both PDA NPs●Tmab@PTX and PDA NPs@Tmab@PTX were found to be highly effective, since they reduced the viability of HER2+ BC cells to a slightly greater extent than free PTX concentrations equivalent to those adsorbed in most of the conditions studied (p < 0.05) (Tables S2–S4). Here, ERBB2 is linked to breast cancer.